![]() |
Volumn 96, Issue 8, 2012, Pages 1153-1154
|
Resistance, not tachyphylaxis or tolerance
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
RANIBIZUMAB;
VASCULOTROPIN INHIBITOR;
ANTIANGIOGENIC ACTIVITY;
CANCER CHEMOTHERAPY;
COLORECTAL CANCER;
DESENSITIZATION;
DRUG APPROVAL;
DRUG PREFERENCE;
DRUG TOLERABILITY;
DRUG TREATMENT FAILURE;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LETTER;
METASTASIS;
NEOVASCULARIZATION (PATHOLOGY);
PRIORITY JOURNAL;
RETINA MACULA AGE RELATED DEGENERATION;
TACHYPHYLAXIS;
TREATMENT RESPONSE;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
CHOROIDAL NEOVASCULARIZATION;
FEMALE;
HUMANS;
MACULAR DEGENERATION;
MALE;
TACHYPHYLAXIS;
|
EID: 84864849235
PISSN: 00071161
EISSN: 14682079
Source Type: Journal
DOI: 10.1136/bjophthalmol-2012-301823 Document Type: Letter |
Times cited : (9)
|
References (7)
|